© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
April 26, 2017
After eight years with no new treatments for ovarian cancer, PARP inhibitors and anti-angiogenics are benefiting patients.
Roundup Herbicide Will Ditch Glyphosate, the Chemical Linked to Cancer
Keeping Faith After a Sarcoma Diagnosis
Bladder Cancer Treatment May Negatively Impact Patients’ Psychosocial Well-being
Why Isn’t Sunscreen Marketed to Men?